Literature DB >> 9862728

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.

B Kessler1, D Hudrisier, M Schroeter, J Tschopp, J C Cerottini, I F Luescher.   

Abstract

This study describes a form of partial agonism for a CD8+ CTL clone, S15, in which perforin-dependent killing and IFN-gamma production were lost but Fas (APO1 or CD95)-dependent cytotoxicity preserved. Cloned S15 CTL are H-2Kd restricted and specific for a photoreactive derivative of the Plasmodium berghei circumsporozoite peptide PbCS 252-260 (SYIPSAEKI). The presence of a photoactivatable group in the epitope permitted assessment of TCR-ligand binding by TCR photoaffinity labeling. Selective activation of Fas-dependent killing was observed for a peptide-derivative variant containing a modified photoreactive group. A similar functional response was obtained after binding of the wild-type peptide derivative upon blocking of CD8 participation in TCR-ligand binding. The epitope modification or blocking of CD8 resulted in an > or = 8-fold decrease in TCR-ligand binding. In both cases, phosphorylation of zeta-chain and ZAP-70, as well as calcium mobilization were reduced close to background levels, indicating that activation of Fas-dependent cytotoxicity required weaker TCR signaling than activation of perforin-dependent killing or IFN-gamma production. Consistent with this, we observed that depletion of the protein tyrosine kinase p56(lck) by preincubation of S15 CTL with herbimycin A severely impaired perforin- but not Fas-dependent cytotoxicity. Together with the observation that S15 CTL constitutively express Fas ligand, these results indicate that TCR signaling too weak to elicit perforin-dependent cytotoxicity or cytokine production can induce Fas-dependent cytotoxicity, possibly by translocation of preformed Fas ligand to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

2.  Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.

Authors:  G Z Tau; S N Cowan; J Weisburg; N S Braunstein; P B Rothman
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

3.  Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.

Authors:  Shoukat Afshar-Sterle; Dimitra Zotos; Nicholas J Bernard; Anna K Scherger; Lisa Rödling; Amber E Alsop; Jennifer Walker; Frederick Masson; Gabrielle T Belz; Lynn M Corcoran; Lorraine A O'Reilly; Andreas Strasser; Mark J Smyth; Ricky Johnstone; David M Tarlinton; Stephen L Nutt; Axel Kallies
Journal:  Nat Med       Date:  2014-02-02       Impact factor: 53.440

4.  IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Authors:  Osamu Imataki; Sascha Ansén; Makito Tanaka; Marcus O Butler; Alla Berezovskaya; Matthew I Milstein; Kiyotaka Kuzushima; Lee M Nadler; Naoto Hirano
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

5.  Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells.

Authors:  J C Symes; C Siatskas; D H Fowler; J A Medin
Journal:  Cancer Gene Ther       Date:  2008-12-19       Impact factor: 5.987

6.  Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Authors:  Anil Shanker; Alan D Brooks; Kristen M Jacobsen; John W Wine; Robert H Wiltrout; Hideo Yagita; Thomas J Sayers
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  Duality of the murine CD8 compartment.

Authors:  Raphaël Genolet; Julie Leignadier; Magne Østerås; Laurent Farinelli; Brian J Stevenson; Immanuel F Luescher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

8.  Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells.

Authors:  Douglas C Braaten; James Scott McClellan; Ilhem Messaoudi; Scott A Tibbetts; Kelly B McClellan; Janko Nikolich-Zugich; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2006-05-19       Impact factor: 6.823

9.  Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors.

Authors:  L E French; J Tschopp
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  The confluence of radiotherapy and immunotherapy.

Authors:  Byron Burnette; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Front Oncol       Date:  2012-10-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.